Molecular Imaging Corporation is a leading national provider of molecular imaging (“MI”) services to the healthcare industry. MI is a powerful diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. MI procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. Unlike Computed Tomography (“CT”) or Magnetic Resonance Imaging (“MRI”), which provide physicians with changes in anatomy, MI detects the altered metabolism typically before anatomical changes occur. MI can help physicians...